Edition:
India

ContraFect Corp (CFRX.OQ)

CFRX.OQ on NASDAQ Stock Exchange Capital Market

1.01USD
17 Nov 2017
Change (% chg)

$0.01 (+1.00%)
Prev Close
$1.00
Open
$1.01
Day's High
$1.01
Day's Low
$0.92
Volume
51,115
Avg. Vol
21,716
52-wk High
$2.65
52-wk Low
$0.80

Chart for

About

ContraFect Corporation is a clinical-stage biotechnology company. The Company is focused on discovering and developing therapeutic protein and antibody products for the treatment of infectious diseases, including those caused by drug-resistant pathogens, particularly those treated in hospital settings. Its pipeline of lysin... (more)

Overall

Beta: --
Market Cap(Mil.): $95.02
Shares Outstanding(Mil.): 73.66
Dividend: --
Yield (%): --

Financials

BRIEF-ContraFect announces Q3 loss per share $0.02

* ContraFect Corp - ‍As of Sept 30, 2017, had cash, cash equivalents and marketable securities of $52.6 million compared to $35.2 million as of December 31, 2016​ Source text for Eikon: Further company coverage:

09 Nov 2017

Earnings vs. Estimates